Showing posts with the label Horizon Therapeutics
View all

Horizon Therapeutics plc Announces Short-Term TEPEZZA® (teprotumumab-trbw) Supply Disruption Due to Government-Mandated (Operation Warp Speed) COVID-19 Vaccine Production

IndustryPRwire -- Horizon Therapeutics announced that it expects a short-term disruption in TEPEZZA (teprotumumab-trbw) supply as a result of recent government-mandated COVID-19 vaccine production or…

AGC Biologics and Horizon Therapeutics plc Expand Partnership

AGC Biologics announced that its partnership with Horizon Therapeutics is expanding to produce Horizon’s Thyroid Eye Disease (TED) treatment, TEPEZZA, at AGC’s new facility in Boulder, CO. The state-…
Subscribe Our Newsletter